Page 22 - MemoriaES-Eng

RESEARCH PROGRAMMES

c

orporate Research Programmes (CRPs) are the corporate scientific work tool
of CIBERES. Up until 2013, a CRP was defined as a collection of research PRO-

JECTS grouped into LINES addressing a relevant health problem in the scope of

respiratory diseases in a cooperative and comprehensive manner.

In 2012, under the guidance of the Scientific Council and with the support of the Cen-
tre’s Scientific Management, the CRP committees made a fundamental change in the

structure of CRPs and reorganized them around one strategic project per programme
that started in 2013 after evaluation by ANEP and CCAE.

The strategic projects have been structured as work packets following the format of

projects funded by the European Commission in the different framework research pro-

grammes and are clearly intended for transferring and translating results, therefore
seeking the public investment to be returned to society as a whole.

As in previous years, for the 2013 fiscal year the CIBERES Steering Committee ap-

proved a budget item for each CRP. This budget item was managed by the Scientific

Committee of each programme which has established the scientific priorities of each
one. The amount assigned to each CRP was variable and was calculated based on

the interest expressed by CIBERES investigators in participating in each of said pro-
grammes and on the external evaluations received:

Resource type
2013 Budget

Severe Asthma
88.541,49€
Pulmonary Fibrosis
34.339,31€

COPD
163.749,97€

Cancer
97.559,60€

Acute Lung Injury
251.275,66€

Sleep Apnea Syndrome
175.866,89€

Pneumonia
254.656,02€

Tuberculosis
89.832,71€

New Therapeutic Targets
247.178,32€

TOTAL
1.402.999,97€

At the same time work on strategic projects began, in 2013 CRPs continued working on
projects taken on in previous years which were all set to end in 2014.

The projects developed and the main results obtained by the CRPs in 2013, as well

as a brief introduction to each of the strategic projects and their objectives are shown

schematically below.
13
20
T
R
PO
E
L R
A
NU
N
A
/
ES
ER
B
CI

22